Search Results - A.I.M. Hoepelman
- Showing 1 - 1 results of 1
-
1
The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial by J. Symons, S.F.L. van Lelyveld, W. de Spiegelaere, A.M.J. Wensing, J. Drylewicz, A.I.M. Hoepelman, P.U. Cameron, H. Lu, T. Mota, A.I. Dantanarayana, L. Vandekerckhove, S.R. Lewin, K. Tesselaar, M. Nijhuis
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book